Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation-Reference-Cited by-同舟云学术

Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation

Published:2019-05-31 Issue:10 Volume:24 Page:1247-1255
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Aizawa Rihito,Takayama Kenji,Nakamura Kiyonao,Inoue Takahiro,Yamasaki Toshinari,Kobayashi Takashi,Akamatsu Shusuke,Ogawa Osamu,Mizowaki Takashi^ORCID

Funder

JSPS KAKENHI

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-019-01478-y.pdf

Reference16 articles.

1. National Comprehensive Cancer Network (2018) NCCN Guidelines; prostate cancer version 2.2018. In: The category of prostate cancer. https://www.nccn.org/professionals/physician_gls/default.aspx#site . Accessed 8 March 2018

2. Tosco L, Briganti A, D'Amico AV et al (2019) Systematic review of systemic therapies and therapeutic combinations with local treatments for high-risk localized prostate cancer. Eur Urol 75(1):44–60. https://doi.org/10.1016/j.eururo.2018.07.027

3. Bolla M, de Reijke TM, Van Tienhoven G et al (2009) Duration of androgen suppression in the treatment of prostate cancer. N Engl J Med 360(24):2516–2527. https://doi.org/10.1056/NEJMoa0810095

4. Denham JW, Joseph D, Lamb DS et al (2019) Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial. Lancet Oncol 20(2):267–281. https://doi.org/10.1016/S1470-2045(18)30757-5

5. Horwitz EM, Bae K, Hanks GE et al (2008) Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer. J Clin Oncol 26(15):2497–2504. https://doi.org/10.1200/JCO.2007.14.9021

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PSMA PET/CT imaging and its application to prostate cancer treatment;Japanese Journal of Radiology;2024-09-03

2. The real prevalence and clinical courses of non-metastatic castration-resistant prostate cancer: A retrospective single-institutional study;2024-02-07

3. Long-term outcomes of whole-pelvis radiation therapy using volumetric modulated arc therapy for high-risk prostate cancer;Journal of Radiation Research;2023-09-01

4. Impact of Long-term Adjuvant Hormonal Therapy in High-dose IMRT for Unfavorable Locally Advanced Prostate Cancer;Anticancer Research;2023-07-26

5. Evaluation of internal margins for prostate for step and shoot intensity‐modulated radiation therapy and volumetric modulated arc therapy using different margin formulas;Journal of Applied Clinical Medical Physics;2022-06-19